Aspen Aerogels Inc (ASPN) Stock Analysis

Verdict: AVOID

High EV customer concentration and operational disruptions leave ASPN vulnerable to structural losses despite PyroThin design wins.

Investment score: 31/100

Analysis as of

Is Aspen Aerogels Inc stock worth reviewing? The TradeMates thesis

The model assigns an Investment Score of 31/100 and recommends AVOID. ASPN suffers from major revenue contraction (-49.1% YoY), deep net losses (-$389.6M in FY2025 including impairments), operational fragility from the April 2026 plant explosion, and sustained insider selling.

7-factor investment score

Aspen Aerogels Inc opportunities and risks

What speaks for ASPN

What speaks against ASPN

Peers and competitors

Trailing-twelve-month ratios
TickerP/EP/SEV/EBITDAGross marginNet marginFCF yield
ASPNn/a2.2xn/a2.7%-62.4%8.4%
MTXn/a0.9x33.9x24.5%-3.1%6.1%
SCLn/a0.6x12.5x11.8%-0.1%-2.4%
ECVTn/a1.3x9.8x21.0%-7.1%6.5%
FTK23.2x3.1x18.5x24.5%13.0%-0.6%
RYAMn/a0.3x7.8x5.9%-9.6%-7.7%
Peer mediann/a0.9x12.5x21.0%-3.1%-0.6%

Frequently asked questions about Aspen Aerogels Inc (ASPN)

Is ASPN stock a good investment?

The TradeMates model rates Aspen Aerogels Inc as AVOID with an investment score of 31/100. The model assigns an Investment Score of 31/100 and recommends AVOID. ASPN suffers from major revenue contraction (-49.1% YoY), deep net losses (-$389.6M in FY2025 including impairments), operational fragility from the April 2026 plant explosion, and sustained insider selling. This is algorithmic model output, not personal investment advice.

Is ASPN stock a buy?

The TradeMates model verdict for ASPN is AVOID with an investment score of 31/100. Treat this as a model signal to review, not a personal buy recommendation.